A feasibility study of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) in evaluation of mediastinal nodal metastasis of lung cancer

A feasibility study of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) in evaluation of mediastinal nodal metastasis of lung cancer - EBUS-TBNA in N2-diagnosis of lung cancer

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000001280

Enrollment

Registered

2008-07-31

Start date

2008-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

EBUS-TBNA is performed in lung cancer patients with suspicion of mediastinal nodal metastasis on chest CT

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1, Resectable and previously untreated non-small cell lung cancer with clinical stage T1-3N0M0 2, Mediastinal nodal enlargement on chest CT (long-axis diameter is 3cm or shorter and enlarger mediastinal nodal station is one or two) 3, PS, 0-2 4, Good major organ function 5, Written informed consent

Exclusion criteria

Exclusion criteria: 1, Active infection 2, Any other active malignant tumor

Design outcomes

Primary

Measure	Time frame
Sensitivity of EBUS-TBNA in the diagnosis of mediastinal nodal metastasis	—

Secondary

Measure	Time frame
Safety profile of EBUS-TBNA, Sensitivity and specificity of positron emission tomography (PET) in the diagnosis of mediastinal nodal metastasis	—

Countries

Japan

Contacts

Public ContactFumihiro Tanaka

Hyogo College of Medicine Thoracic surgery

ftanaka@hyo-med.ac.jp0798-45-6885

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026